SDIX » Topics » CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

This excerpt taken from the SDIX 10-K filed Mar 15, 2006.

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors
Strategic Diagnostics Inc.:

We consent to incorporation by reference in the registration statements (Nos. 333-20421, 333-21211, 333-68107, 333-68484 and 333-118297) on Form S-8 of Strategic Diagnostics Inc. of our report dated February 28, 2005, except for Note 2, which is as of February 17, 2006, relating to the consolidated balance sheets of Strategic Diagnostics Inc. and subsidiaries as of December 31, 2004 and 2003, and the related consolidated statements of operations, stockholders’ equity and comprehensive income and cash flows for each of the years in the three-year period ended December 31, 2004, which report appears in the December 31, 2004 annual report on Form 10-K/A of Strategic Diagnostics Inc.

Our report refers to the restatement of the consolidated financial statements for all periods presented, as discussed in Note 2 to the consolidated financial statements, to change the Company’s method of accounting for custom antibody projects.

/s/    KPMG LLP

Philadelphia, Pennsylvania
February 17, 2006


This excerpt taken from the SDIX 10-K filed Feb 22, 2006.

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors
Strategic Diagnostics Inc.:

We consent to incorporation by reference in the registration statements (Nos. 333-20421, 333-21211, 333-68107, 333-68484 and 333-118297) on Form S-8 of Strategic Diagnostics Inc. of our report dated February 28, 2005, except for Note 2, which is as of February 17, 2006, relating to the consolidated balance sheets of Strategic Diagnostics Inc. and subsidiaries as of December 31, 2004 and 2003, and the related consolidated statements of operations, stockholders’ equity and comprehensive income and cash flows for each of the years in the three-year period ended December 31, 2004, which report appears in the December 31, 2004 annual report on Form 10-K/A of Strategic Diagnostics Inc.

Our report refers to the restatement of the consolidated financial statements for all periods presented, as discussed in Note 2 to the consolidated financial statements, to change the Company’s method of accounting for custom antibody projects.

/s/    KPMG LLP

Philadelphia, Pennsylvania
February 17, 2006


This excerpt taken from the SDIX 10-K filed Mar 31, 2005.

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

The Board of Directors

Strategic Diagnostics Inc.:

 

We consent to incorporation by reference in the registration statements (Nos. 333-20421, 333-21211, 333-68107, 333-68484 and 333-118297) on Form S-8 of Strategic Diagnostics Inc. of our report dated February 28, 2005, relating to the consolidated balance sheets of Strategic Diagnostics Inc. and subsidiaries as of December 31, 2004 and 2003, and the related consolidated statements of operations, stockholders’ equity and comprehensive income and cash flows for each of the years in the three-year period ended December 31, 2004, which report appears in the December 31, 2004 annual report on Form 10-K of Strategic Diagnostics Inc.

 

/s/    KPMG LLP

Philadelphia, Pennsylvania

March 28, 2005

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki